Cargando…

1566. Population Pharmacokinetics of Voriconazole: Serum Albumin Status as a Novel Marker of Clearance and Dosage Optimization

BACKGROUND: Voriconazole (VRCZ) is a first-line agent for the treatment of invasive aspergillosis. In this study, we report the first study on population pharmacokinetics (PPK) of VRCZ in Thai patients. METHODS: A PPK study was performed by combining blood VRCZ data from intensive pharmacokinetic (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chantharit, Prawat, Tantasawat, Montira, Kasai, Hidefumi, Tanigawara, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809812/ http://dx.doi.org/10.1093/ofid/ofz360.1430

Ejemplares similares

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole
por: Imamura, Chiyo K., et al.
Publicado: (2015)

Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid
por: Kasai, Hidefumi, et al.
Publicado: (2020)

Pharmacodynamic analysis of hypertension caused by lenvatinib using real‐world postmarketing surveillance data
por: Otani, Yuki, et al.
Publicado: (2021)

Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data
por: Otani, Yuki, et al.
Publicado: (2021)

Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases
por: Khan-asa, Buddharat, et al.
Publicado: (2020)

Bartolomé de las Casas, 1484-1566 /
por: Beuchot, Mauricio
Publicado: (1995)

An Illustrated Broadside of 1566 Announcing the Birth of Quintuplets
por: McDaniel, W. B.
Publicado: (1942)

Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
por: Ruangritchankul, Sirasa, et al.
Publicado: (2021)

The index of scientific writings on creativity. General: 1566–1974
Publicado: (1979)

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study
por: Hope, William, et al.
Publicado: (2019)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade
por: Zheng, Ming
Publicado: (2022)

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
por: Hirai, Toshinori, et al.
Publicado: (2022)

Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study
por: Booka, Eisuke, et al.
Publicado: (2015)

1566. Is Primary CMV Infection Post-transplant Influenced by Circadian Rhythms?
por: Rafferty, Hannah, et al.
Publicado: (2018)

P1566: COMPLICATIONS ASSOCIATED WITH CENTRAL VENOUS CATHETERIZATION IN ONKOHEMATOLOGY PRACTICE
por: Romanenko, Nikolay
Publicado: (2023)

Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation
por: Tanigawara, Yusuke, et al.
Publicado: (2011)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
por: Wang, Taotao, et al.
Publicado: (2018)

A retrospective analysis of patient-specific factors on voriconazole clearance
por: Dote, Satoshi, et al.
Publicado: (2016)

Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population
por: Herman, Bumi, et al.
Publicado: (2023)

Comparison of the noise produced by the polymer and bronze P1566 propellers in the cavitation tunnel
por: Szymak, Piotr, et al.
Publicado: (2023)

Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
por: Kenmotsu, Hirotsugu, et al.
Publicado: (2015)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
por: Lee, Ji-Sang, et al.
Publicado: (2021)

1566 Factors Associated with 10 Years of Continuous HIV Viral Load Suppression on HAART
por: Bello, Kathryn, et al.
Publicado: (2014)

2566. Effect of CYP2C19 on Voriconazole Pharmacokinetics in Children with Malignancy or Inborn Errors in Immunity
por: Shoji, Kensuke, et al.
Publicado: (2023)

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data
por: Kawamura, Takahisa, et al.
Publicado: (2018)

Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants
por: Kim, Daniel Seung, et al.
Publicado: (2014)

Treatment of Cryptococcus gattii Infection Using Voriconazole
por: Nakao, Makoto, et al.
Publicado: (2021)

Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36
por: Temsangsukmanee, Jirat, et al.
Publicado: (2023)

Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate
por: Kaminsky, R., et al.
Publicado: (2008)

In Vitro and In Vivo Efficacy of Monepantel (AAD 1566) against Laboratory Models of Human Intestinal Nematode Infections
por: Tritten, Lucienne, et al.
Publicado: (2011)

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
por: Nyga, Rémy, et al.
Publicado: (2019)

Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism
por: Schulz, Josefine, et al.
Publicado: (2022)

Impact of polymorphisms of pharmacokinetics‐related genes and the inflammatory response on the metabolism of voriconazole
por: Aiuchi, Naoya, et al.
Publicado: (2022)

Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections
por: Tanigawara, Yusuke, et al.
Publicado: (2013)

Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration
por: Parsley, Ruth A., et al.
Publicado: (2018)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients
por: Hu, Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_05ihqpnkc7luhb8b845v3lq59g